Activest Wealth Management’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07K Buy
60
+59
+5,900% +$1.06K ﹤0.01% 951
2026
Q1
$18 Buy
+1
New +$22 ﹤0.01% 1209

Other funds holding CAI

Activest Wealth Management's CAI Position: Q2 2026 in Review

Activest Wealth Management increased its Caris Life Sciences (CAI) stake by 5,900% in Q2 2026, buying an estimated $1.06K and bringing the position to 60 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Activest Wealth Management first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Activest Wealth Management held 60 shares of Caris Life Sciences worth $1.07K as of Q2 2026.
  • Activest Wealth Management bought 59 Caris Life Sciences shares in Q2 2026, an estimated $1.06K.
  • Caris Life Sciences made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #951 holding.
  • Activest Wealth Management first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.